These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7672483)

  • 41. [Role of amylin in glucose homeostasis and its perspective use in diabetes management].
    Otto-Buczkowska E; Mazur-Dworzecka U; Dworzecki T
    Przegl Lek; 2008; 65(3):135-9. PubMed ID: 18624122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amylin and gastrointestinal activity.
    Guidobono F
    Gen Pharmacol; 1998 Aug; 31(2):173-7. PubMed ID: 9688456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of rat amylin on renal function in the rat.
    Vine W; Smith P; LaChappell R; Blase E; Young A
    Horm Metab Res; 1998 Aug; 30(8):518-22. PubMed ID: 9761383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accelerated gastric emptying of glucose in Zucker type 2 diabetic rats: role in postprandial hyperglycaemia.
    Green GM; Guan D; Schwartz JG; Phillips WT
    Diabetologia; 1997 Feb; 40(2):136-42. PubMed ID: 9049472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of gastric emptying as a therapeutic approach to glycaemic control.
    Moyses C; Young A; Kolterman O
    Diabet Med; 1996 Sep; 13(9 Suppl 5):S34-8. PubMed ID: 8894469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amylin, food intake, and obesity.
    Reda TK; Geliebter A; Pi-Sunyer FX
    Obes Res; 2002 Oct; 10(10):1087-91. PubMed ID: 12376591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus.
    Nowak TV; Johnson CP; Kalbfleisch JH; Roza AM; Wood CM; Weisbruch JP; Soergel KH
    Gut; 1995 Jul; 37(1):23-9. PubMed ID: 7672674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas.
    Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1993 Mar; 25(3):135-7. PubMed ID: 8477949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.
    Koopmans SJ; van Mansfeld AD; Jansz HS; Krans HM; Radder JK; Frölich M; de Boer SF; Kreutter DK; Andrews GC; Maassen JA
    Diabetologia; 1991 Apr; 34(4):218-24. PubMed ID: 2065857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracisternal injection of pancreatic polypeptide stimulates gastric emptying in rats.
    Okumura T; Pappas TN; Taylor IL
    Neurosci Lett; 1994 Aug; 178(1):167-70. PubMed ID: 7816328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
    Hartter E; Svoboda T; Ludvik B; Schuller M; Lell B; Kuenburg E; Brunnbauer M; Woloszczuk W; Prager R
    Diabetologia; 1991 Jan; 34(1):52-4. PubMed ID: 2055340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Islet amyloid polypeptide (IAPP;amylin) influences the endocrine but not the exocrine rat pancreas.
    Fehmann HC; Weber V; Göke R; Göke B; Eissele R; Arnold R
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1102-8. PubMed ID: 1690993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.
    Weyer C; Maggs DG; Young AA; Kolterman OG
    Curr Pharm Des; 2001 Sep; 7(14):1353-73. PubMed ID: 11472273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats.
    Reidelberger RD; Kelsey L; Heimann D
    Am J Physiol Regul Integr Comp Physiol; 2002 May; 282(5):R1395-404. PubMed ID: 11959682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats.
    Novials A; Rodriguez-Mañas L; Chico A; El Assar M; Casas S; Gomis R
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1446-50. PubMed ID: 17213278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired intracellular signal transduction in gastric smooth muscle of diabetic BB/W rats.
    Takahashi T; Kojima Y; Tsunoda Y; Beyer LA; Kamijo M; Sima AA; Owyang C
    Am J Physiol; 1996 Mar; 270(3 Pt 1):G411-7. PubMed ID: 8638706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experimental study of amylin-induced functional damage to rat pancreatic islet cells in vitro].
    Zhou L; Xue YM
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):922-4. PubMed ID: 13129721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence of accelerated gastric emptying in longstanding diabetic patients after ingestion of a semisolid meal.
    Lipp RW; Schnedl WJ; Hammer HF; Kotanko P; Leb G; Krejs GJ
    J Nucl Med; 1997 May; 38(5):814-8. PubMed ID: 9170452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.